Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-01-09 17:54:21
Reporting Period:
Filing Date:
Accepted Time:
2017-01-09 17:54:21
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1281895 Inotek Pharmaceuticals Corp ITEK () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1251553 P David Southwell C/o Inotek Pharmaceuticals Corporation
91 Hartwell Avenue, 2Nd Floor
Lexington MA 02421
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-01-06 60,000 $1.75 62,765 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.749 to $1.75, inclusive. The reporting person undertakes to provide to Inotek Pharmaceuticals Corporation, any security holder of Inotek Pharmaceuticals Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  2. Includes 2,765 shares of the Issuer's common stock acquired under the Issuer's Employee Stock Purchase Plan since the date of the Reporting Person's last Form 4 with Table I Information.